Mito Health

Mito Health

Private
Singapore, Central SingaporeHealthcare & Life Scienceshttps://mitohealth.com/

Last Round

Seed

Mar 18, 2025

Total Funding Raised

$3.5M

Company Overview

Mito Health is an AI-powered preventive healthcare company that provides personalized health plans based on comprehensive biomarker analysis. The company uses blood tests, diagnostic scans, and user-provided health data to offer insights and recommendations aimed at preventing disease, improving longevity, and optimizing health. The platform, co-piloted by AI and doctors, creates individualized action plans that include supplement, exercise, nutrition, and sleep strategies. Founded by a team that includes a medical doctor and exited founders, Mito Health was part of the Y Combinator accelerator program and serves customers in Singapore and the United States.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Healthcare Analytics, D2C Brands, Medical AI

Business Model

B2C

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

biomarker testingpersonalized health planat-home health testpreventive healthcarelongevityhealth analytics platformbiological age testingbiohackinghealthspanhealth optimizationDTC healthAI health insightsclinician consultationdigital health dashboardcorporate wellnessgut microbiome testingHSA/FSA eligible

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mito Health Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Mito Health Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedMar 18, 2025
Pre SeedApr 18, 2023

Key People

Founding team and executive leadership

Joel Kek

Co-Founder CTO

Founding Team

Tee-Ming C.

Co-Founder CPO

Founding Team

Mito Health Investors

Notable investors and investment history

InvestorRounds
CAPITAL X株式会社Seed
Forge VenturesSeed, Pre Seed
XA NetworkSeed
Y CombinatorSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 5, 2025

    Official bloodwork partner at the Vitalist Bay 2025 event.

  • Mar 18, 2025

    Will offer customers DEXA scans for deeper health insights.

Mito Health Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Mito Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mito Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersSingapore, Central Singapore
Employee Range13
Year Founded2023
Last FundingMar 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.